July 04, 2012
Under the agreement Chitinor will acquire production facilities in Tromsø, Norway, inventories, patents, Chitopharm™ trademark, product and application technologies, and global customer portfolio for all chitosan product ranges, including functional cosmetic ingredients and Chitopharm™ pharmaceutical ingredients with corresponding Drug Master Files...Chitinor’s track-record and know-how related to chitin based biopolymers will provide our customers with a strong supply-chain for top quality products unmatched by anyone. Importantly, the acquisition also represents a valuable addition to our customer portfolio in the cosmetic and pharmaceutical markets,” adds Bjarte Langhelle, Commercial Director of Seagarden ASA.
About Chitinor AS
Chitinor AS is a leading producer and supplier of marine biopolymers based on shells from North-Atlantic cold-water shrimp, Pandalus borealis...Chitinor AS is a fully owned subsidiary of Seagarden ASA, Haugesund, Norway.
About Seagarden ASA
Seagarden ASA is a Norwegian Public Company with around 80 shareholders. The company is registered in Haugesund, Norway, and is the holding company for Seagarden AS, Chitinor AS, Atlantic Ingredients AS, Arctic Medical Nutrition AS and Avaldsnes Property AS...Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success, social responsibility and environmental protection. Through science and innovation we enable our customers in almost all industries to meet the current and future needs of society. Our products and system solutions contribute to the conservation of resources, the provision of healthy food and nutrition and improving the quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future...Internet at http://www.basf.com
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/7/prweb9668029.htm